BNQPR - ULTRA TAG RBC TECHNETIUM TC99M LABLED RED (

  • MSDS: BNQPR
  • Manufacturer: MALLINCKRODT MEDICAL INC
  • Product Name: ULTRA TAG RBC TECHNETIUM TC99M LABLED RED (
  • National Stock Number: 6505-00N030329
Product Identification

Product ID:ULTRA TAG RBC TECHNETIUM TC99M LABLED RED (
MSDS Date:01/01/1992
FSC:6505
NIIN:00N030329
MSDS Number: BNQPR

Responsible Party
MALLINCKRODT MEDICAL INC
2703 WAGNER PLACE
MARYLAND HEIGHTS, MO 63043
US

Emergency Phone: 314-344-3800

Info Phone: 314-344-3800

Cage: FO650

Contractor
MALLINCKRODT MEDICAL INC
MARYLAND HEIGHTS, MO 63043-3421 US

Telephone: 314-770-7800/314-895-2000

Cage: FO650

Ingredients

2); (STANNOUS CHLORIDE, SOLID)

CAS: 7772-99-8

RTECS: XP8700000

Fraction By Weight: 0.8%


D-GLUCOSE; (DEXTROSE)

CAS: 50-99-7

RTECS: LZ6600000

Fraction By Weight: 59.5%


SODIUM CITRATE

CAS: 6132-04-3

Fraction By Weight: 39.7%


SYRINGE I (CONSISTING OF INGREDIENTS 6 & 7)

RTECS: 9999999ZZ


HYPOCHLOROUS ACID, SODIUM SALT; (SODIUM HYPOCHLORITE)

CAS: 7681-52-9

RTECS: NH3486300

Fraction By Weight: 0.1%

EPA Report Quantity: 100 LBS

DOT Report Quantity: 100 LBS


WATER

CAS: 7732-18-5

RTECS: ZC0110000

Fraction By Weight: 99.9%


SYRINGE II (CONSISTING OF INGREDIENTS 9 THROUGH 12)

RTECS: 9999999ZZ


CITRIC ACID; (CITRIC ACID, ANHYDROUS)

CAS: 77-92-9

RTECS: GE7350000

Fraction By Weight: 0.9%


D-GLUCOSE; (DEXTROSE ANHYDROUS)

CAS: 50-99-7

RTECS: LZ6600000

Fraction By Weight: 1.2%


SODIUM CITRATE (HYDRATED FORM)

CAS: 6132-04-3

Fraction By Weight: 3.3%


WATER

CAS: 7732-18-5

RTECS: ZC0110000

Fraction By Weight: 95 - 99%


W/APPROP REGS OF GOVT AGENCY AUTHORIZED TO LICENSE

RTECS: 9999999ZZ


OF MEDICAL WASTES AS APPROPRIATE.

RTECS: 9999999ZZ


REACTION VIAL (CONSISTING OF INGREDIENTS 2 THRU 4)

RTECS: 9999999ZZ

Hazards

LD50 LC50 Mixture:NONE SPECIFIED BY MANUFACTURER.
Routes of Entry: Inhalation:NO Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:THE HAZARDOUS INGREDIENTS FOUND IN
ULTRA TAG RBC ARE SKIN & EYE IRRITANTS, BUT DUE TO THE SMALL
QUANTITIES PRESENT IN EACH CONTAINER, NO ADVERSE HEALTH EFFECTS ARE
EXPECTED TO OCCUR FROM EXPOSURE.
Explanation of Carcinogenicity:NOT RELEVANT
Effects of Overexposure:NONE SPECIFIED BY MANUFACTURER.
Medical Cond Aggravated by Exposure:NO INFORMATION FOUND.

First Aid

First Aid:INGEST:CALL MD IMMEDIATELY . INHAL: REMOVE TO FRESH AIR.
SUPPORT BREATHING (GIVE O2/ARTF RESP) . SKIN: WASH EXPOSED AREA
W/SOAP & WATER. GET MD IF IRRITATION DEVELOPS. EYE:WASH THOROUGHLY
W/RUNNING WATER. GET MD IF IRRITATION DEVELOPS.

Fire Fighting

Extinguishing Media:USE ANY MEANS SUITABLE FOR EXTINGUISHING
SURROUNDING FIRE.
Fire Fighting Procedures:WEAR NIOSH/MSHA APPROVED SCBA & FULL
PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:NOT CONSIDERED TO BE AN EXPLOSION HAZARD.

Accidental Release

Spill Release Procedures:COLLECT NON-RADIOACTIVE SPILLS & DISP OF MATL
AS NON-HAZ WASTE. IF ANY LOSS/RELEASE OF RADIOACTIVE CONTENTS
OCCURS, NOTIFY YOUR RADIA SAFTY DEPT & MFR @ (314)344-3800. ALL
CLEANUP OPERATIONS SHLD BE P ERFORMED ACCORDING TO STD OPERATING
PROCS (SUPDAT)
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

Handling

Handling and Storage Precautions:PROTECT FROM LIGHT UNTIL USE (SYRINGE
I). HANDLING DEVICES SUCH AS SYRINGE SHIELDS & TONGS SHOULD BE
USED.
Other Precautions:DRUG SHLD BE STORED @/BELOW ROOM TEMP(2C-25C) BOTH
PRIOR TO & FOLLOWING RECONSTITUTION W/SODIUM PERTECHNETATE TC-99M &
DISCARDED 6 HRS FROM TIME OF PREPARATION. AFTER RECONSTITUTION,
HNDLG TIME SHLD B E KEPT TO MIN & APPROP SHIELDING(SUPDAT)

Exposure Controls

Respiratory Protection:NOT EXPECTED TO REQUIRE PERSONAL RESPIRATOR
USAGE. USE NIOSH/MSHA APPROVED RESPIRATOR APPROPRIATE FOR EXPOSURE
OF CONCERN .
Ventilation:NOT EXPECTED TO REQUIRE ANY SPECIAL VENTILATION.
Protective Gloves:IMPERVIOUS GLOVES .
Eye Protection:CHEMICAL WORKERS GOGGLES .
Other Protective Equipment:CLEAN BODY-COVERING CLOTHING. EMERGENCY EYE
WASH & DELUGE SHOWER .
Work Hygienic Practices:AVOID ALL UNNECESSARY EXPOSURE TO CHEMICAL
SUBSTANCE & ENSURE PROMPT REMOVAL FROM SKIN, EYES & CLOTHING.
Supplemental Safety and Health
MFR'S TRADE NAME/PART NO:BLOOD CELLS. APPEAR/ODOR:SYRINGES PARTIALLY
FILLED W/COLORLESS SOLN; ODORLESS. SPILL PROC:(SOP'S) ESTABLISHED
BY YOUR RADIA SAFETY OFFICER. WASTE DISP METH: COMPLIANCE W/LOC,
STATE & FED REGS. OTHER PREC:SHLD BE USED. STOR & DISP OF PROD SHLD
BE CONTROLLED IN MANNER THAT IS IN COMPLIANCE(ING 13

Chemical Properties

HCC:N1
Boiling Pt:B.P. Text:212F,100C
Melt/Freeze Pt:M.P/F.P Text:32.0F,0.0C
Solubility in Water:SOLUBLE
Appearance and Odor:SMALL, DRY CRYSTALS CLINGING TO INSIDE OF 10 ML
GLASS RXN VIAL & (2) (SUPDAT)

Stability

Stability Indicator/Materials to Avoid:YES
NO INFORMATION FOUND.
Stability Condition to Avoid:LIGHT SENSITIVE (SYRINGE I).
Hazardous Decomposition Products:WHEN HEATED TO DECOMP, SUBSTANCE MAY
EMIT COX & CORROSIVE FUMES OF HYDROCHLORIC ACID.

Disposal

Waste Disposal Methods:RADIOACTIVE WASTE SHOULD BE DISPOSED OF
ACCORDING TO SOP'S ESTABLISHED BY YOUR RADIA SAFETY OFFICER. AFTER
ADDN OF BLOOD SAMPLE:ANY RESULTING WASTE MATL IS CONSIDERED BIOHAZ
WASTE & SHOULD BE HNDLD I/ A/W BIOHAZ/MED WASTE REGS. ENSURE
(SUPPDATA)

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.